← Back to headlines
Akebia Therapeutics Q4 Earnings Report
Akebia Therapeutics reported a GAAP EPS of -$0.05, missing estimates, while its revenue of $57.6 million beat expectations.
26 Feb, 12:07 — 26 Feb, 12:07
ℹOnly 1 source covers this story
Akebia Therapeutics reported a GAAP EPS of -$0.05, missing estimates, while its revenue of $57.6 million beat expectations.